Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin Toxicity
Natalie C. Ward, Gerald F. Watts, Robert H. Eckel
Circulation Research (2019) Vol. 124, Iss. 2, pp. 328-350
Open Access | Times Cited: 599

Showing 1-25 of 599 citing articles:

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
Ting Cai, Lucy Abel, Oliver Langford, et al.
BMJ (2021), pp. n1537-n1537
Open Access | Times Cited: 173
The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis
Shulan Pi, Ling Mao, Jiefang Chen, et al.
Autophagy (2020) Vol. 17, Iss. 4, pp. 980-1000
Open Access | Times Cited: 144
Sex- and Gender-Based Pharmacological Response to Drugs
Franck Mauvais‐Jarvis, Heiner K. Berthold, Ilaria Campesi, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 730-762
Open Access | Times Cited: 135
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Massimiliano Ruscica, Nicola Ferri, Maciej Banach, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3288-3304
Open Access | Times Cited: 101
Coronary Atherosclerotic Plaque Regression
L. Dawson, Mark Lum, Nitesh Nerleker, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 1, pp. 66-82
Open Access | Times Cited: 100
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala, et al.
Journal of clinical lipidology (2022) Vol. 16, Iss. 4, pp. 361-375
Open Access | Times Cited: 99
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
Atena Mansouri, Željko Reiner, Massimiliano Ruscica, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1313-1313
Open Access | Times Cited: 89
Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis
Qi Zhang, Hang Qu, Yinghui Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 77
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Statins Neuromuscular Adverse Effects
Silvia Attardo, Olimpia Musumeci, Daniele Velardo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8364-8364
Open Access | Times Cited: 69
Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment
Vismitha Rajeev, Yuek Ling Chai, Luting Poh, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease
Sung‐Jin Hong, Yong‐Joon Lee, Seung‐Jun Lee, et al.
JAMA (2023) Vol. 329, Iss. 13, pp. 1078-1078
Open Access | Times Cited: 55
Potential Benefits and Risks Associated with the Use of Statins
Nisha Khatiwada, Zhongkui Hong
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 214-214
Open Access | Times Cited: 22
Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
Zhaohui Gong, Haixin Yang, Li Gao, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Statins as Anticancer Agents in the Era of Precision Medicine
Joseph Longo, Jenna E. van Leeuwen, Mohamad Elbaz, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 22, pp. 5791-5800
Open Access | Times Cited: 133
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Gerald F. Watts, Samuel S. Gidding, Pedro Mata, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 6, pp. 360-377
Closed Access | Times Cited: 117
Targeting the Mevalonate Pathway in Cancer
Dennis Juarez, David A. Fruman
Trends in cancer (2021) Vol. 7, Iss. 6, pp. 525-540
Open Access | Times Cited: 91
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wenjun Wang, Ling Bai, Wei Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 81
Response by Ward et al to Letter Regarding Article, “Statin Toxicity: Mechanistic Insights and Clinical Implications”
Natalie C. Ward, Gerald F. Watts, Robert H. Eckel
Circulation Research (2019) Vol. 124, Iss. 12
Open Access | Times Cited: 79
Statins Are Associated With Increased Insulin Resistance and Secretion
Fahim Abbasi, Cindy Lamendola, Chelsea S. Harris, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 11, pp. 2786-2797
Open Access | Times Cited: 76
The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins
Christopher L. Murphy, Evelyne Deplazes, Charles G. Cranfield, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8745-8745
Open Access | Times Cited: 73
Araloside C attenuates atherosclerosis by modulating macrophage polarization via Sirt1-mediated autophagy
Yun Luo, Shan Lu, Ye Gao, et al.
Aging (2020) Vol. 12, Iss. 2, pp. 1704-1724
Open Access | Times Cited: 72
The Fatty Acid Lipid Metabolism Nexus in COVID-19
Jerome E. Tanner, Caroline Alfieri
Viruses (2021) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 70
Posttranslational Regulation of HMG CoA Reductase, the Rate-Limiting Enzyme in Synthesis of Cholesterol
Marc Schumacher, Russell A. DeBose‐Boyd
Annual Review of Biochemistry (2021) Vol. 90, Iss. 1, pp. 659-679
Open Access | Times Cited: 62
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Bruce A. Warden, John R. Guyton, Adrienne C Kovacs, et al.
Journal of clinical lipidology (2022) Vol. 17, Iss. 1, pp. 19-39
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top